Stephen W. Kidder’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$236K Hold
4,100
– – 0.06% 72
2026
Q1
$249K Hold
4,100
– – 0.07% 69
2025
Q4
$221K Buy
+4,100
New +$197K 0.06% 70
2025
Q3
– Sell
-4,750
Closed -$220K – 75
2025
Q2
$220K Buy
4,750
+150
+3% +$7.36K 0.07% 73
2025
Q1
$281K Hold
4,600
– – 0.09% 61
2024
Q4
$260K Hold
4,600
– – 0.08% 60
2024
Q3
$238K Sell
4,600
-550
-11% -$25.8K 0.07% 66
2024
Q2
$214K Sell
5,150
-50
-1% -$2.24K 0.07% 68
2024
Q1
$282K Sell
5,200
-141
-3% -$7.18K 0.09% 60
2023
Q4
$274K Sell
5,341
-140
-3% -$7.35K 0.09% 65
2023
Q3
$318K Hold
5,481
– – 0.11% 62
2023
Q2
$351K Hold
5,481
– – 0.11% 62
2023
Q1
$380K Sell
5,481
-100
-2% -$7.05K 0.13% 60
2022
Q4
$402K Buy
+5,581
New +$421K 0.15% 60
2019
Q1
– Sell
-4,850
Closed -$252K – 75
2018
Q4
$252K Hold
4,850
– – 0.11% 69
2018
Q3
$301K Sell
4,850
-500
-9% -$29.7K 0.11% 78
2018
Q2
$297K Sell
5,350
-150
-3% -$8.1K 0.11% 79
2018
Q1
$347K Sell
5,500
-1,100
-17% -$70.8K 0.13% 72
2017
Q4
$405K Buy
6,600
+1,600
+32% +$100K 0.15% 72
2017
Q3
$318K Sell
5,000
-200
-4% -$11.7K 0.12% 78
2017
Q2
$290K Hold
5,200
– – 0.11% 80
2017
Q1
$283K Sell
5,200
-500
-9% -$27.4K 0.11% 83
2016
Q4
$334K Hold
5,700
– – 0.14% 79
2016
Q3
$307K Sell
5,700
-2,500
-30% -$161K 0.12% 80
2016
Q2
$603K Sell
8,200
-200
-2% -$14.1K 0.24% 64
2016
Q1
$536K Hold
8,400
– – 0.22% 64
2015
Q4
$578K Hold
8,400
– – 0.25% 63
2015
Q3
$497K Sell
8,400
-100
-1% -$6.34K 0.25% 61
2015
Q2
$565K Sell
8,500
-1,500
-15% -$98.9K 0.26% 60
2015
Q1
$644K Sell
10,000
-500
-5% -$31.3K 0.28% 61
2014
Q4
$620K Hold
10,500
– – 0.27% 65
2014
Q3
$537K Buy
+10,500
New +$524K 0.24% 64

Other funds holding BMY

Stephen W. Kidder's BMY Position: Q2 2026 in Review

Stephen W. Kidder held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,100 shares worth $236K. The position accounts for 0.06% of the portfolio, ranked #72.

Stephen W. Kidder first reported a position in BMY in Q3 2014 and has held it in 32 quarters since. The position peaked at $644K in Q1 2015. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Stephen W. Kidder held 4,100 shares of Bristol-Myers Squibb worth $236K as of Q2 2026.
  • Stephen W. Kidder left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.06% of Stephen W. Kidder's portfolio in Q2 2026, its #72 holding.
  • Stephen W. Kidder first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 32 quarters since.
  • Stephen W. Kidder's Bristol-Myers Squibb position peaked at $644K in Q1 2015.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Stephen W. Kidder's 13F filing for Q2 2026, filed 21 Aug 2026.